CompletedNot Applicable

An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections

United States77 participantsStarted 2022-05-18

Plain-language summary

In July 2020, a bundle (Appendix C) was implemented at Methodist Dallas Medical Center where all patients with SAB were reviewed by the antimicrobial stewardship pharmacist (Monday - Friday from 0700 to 1500), a note outlining optimal interventions was written in the electronic medical record (EMR), and the recommendations were communicated to the primary team via secure messaging or telephone

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years of age SAB during hospital admission Exclusion Criteria: * Patients with a history of a prior SAB during the study period (only first occurrence included) * Blood culture collected within 48hours of patient expiring or transitioning to hospice * Patients discharged or left before culture results were available * Patients transferred from an outside hospital

What they're measuring

number of Staphylococcus Aureus blood stream infections (SAB)

Timeframe: 12 weeks

Trial details

NCT IDNCT06211829

SponsorMethodist Health System

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-14

View on ClinicalTrials.gov More Bacterial Infections trials